Skip to main content

LMR Partners LLP

Position in ALT — Altimmune, Inc.

CIK 1578621 LONDON, X0

Position in ALT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$912,000
+$690,707 QoQ
Shares Held
300,000
+389.4% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 210 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALT Over Time

Shares Held

Position Value (USD)

Derivatives in ALT

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$902,500
PutShares
250,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. ALT ranks #35 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $912,000 300,000
2025-12-31 $902,500 250,000
2025-12-31 $221,293 61,300
2025-09-30 $942,500 250,000
2025-06-30 $1,365,336 352,800
2023-12-31 $281,250 25,000
2023-09-30 $115,720 44,508
2023-03-31 $324,838 76,976
2022-09-30 $180,555 14,139
2022-06-30 $165,426 14,139
2021-12-31 $183,200 20,000
2021-09-30 $455,216 40,249
2021-03-31 $301,223 21,318